These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32057333)

  • 1. Measles antibody levels among vaccinated and unvaccinated children 6-59 months of age in the Democratic Republic of the Congo, 2013-2014.
    Ashbaugh HR; Cherry JD; Hoff NA; Doshi RH; Alfonso VH; Gadoth A; Mukadi P; Higgins SG; Budd R; Randall C; Mwamba GN; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Gerber SK; Rimoin AW
    Vaccine; 2020 Feb; 38(9):2258-2265. PubMed ID: 32057333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of measles vaccination coverage among children 6-59 months of age in the Democratic Republic of the Congo.
    Ashbaugh HR; Hoff NA; Doshi RH; Alfonso VH; Gadoth A; Mukadi P; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Gerber SK; Cherry JD; Rimoin AW
    Vaccine; 2018 Jan; 36(4):587-593. PubMed ID: 29248265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Field challenges to measles elimination in the Democratic Republic of the Congo.
    Coulborn RM; Nackers F; Bachy C; Porten K; Vochten H; Ndele E; Van Herp M; Bibala-Faray E; Cohuet S; Panunzi I
    Vaccine; 2020 Mar; 38(13):2800-2807. PubMed ID: 32111528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Field evaluation of measles vaccine effectiveness among children in the Democratic Republic of Congo.
    Doshi RH; Mukadi P; Shidi C; Mulumba A; Hoff NA; Gerber S; Okitolonda-Wemakoy E; Ilunga BK; Muyembe JJ; Rimoin AW
    Vaccine; 2015 Jun; 33(29):3407-14. PubMed ID: 25937449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reported History of Measles and Long-term Impact on Tetanus Antibody Detected in Children 9-59 Months of Age and Receiving 3 Doses of Tetanus Vaccine in the Democratic Republic of the Congo.
    Ashbaugh HR; Cherry JD; Hoff NA; Doshi RH; Mukadi P; Higgins SG; Budd R; Randall C; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Gerber SK; Wells C; Rimoin AW
    Pediatr Infect Dis J; 2023 Apr; 42(4):338-345. PubMed ID: 36795582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetanus seroprotection among children in the Democratic Republic of the Congo, 2013-2014.
    Cheng A; Ghanem-Uzqueda A; Hoff NA; Ashbaugh H; Doshi RH; Mukadi P; Budd R; Higgins SG; Randall C; Gerber S; Kabamba M; Ngoie Mwamba G; Okitolonda-Wemakoy E; Muyembe-Tanfum JJ; Rimoin AW
    PLoS One; 2022; 17(5):e0268703. PubMed ID: 35587922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles seroprevalence after reactive vaccination campaigns during the 2015 measles outbreak in four health zones of the former Katanga Province, Democratic Republic of Congo.
    Keating P; Carrion Martin AI; Blake A; Lechevalier P; Uzzeni F; Gignoux E; Okonta C; Langendorf C; Smit S; Ahuka S; Suchard M; Pukuta E; Degail MA; Hansen L; Kibanza-Kyungu J; Ciglenecki I; Cohuet S
    BMC Public Health; 2019 Aug; 19(1):1153. PubMed ID: 31438898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual- and community-level determinants of child immunization in the Democratic Republic of Congo: A multilevel analysis.
    Acharya P; Kismul H; Mapatano MA; Hatløy A
    PLoS One; 2018; 13(8):e0202742. PubMed ID: 30138459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Previous Measles Infection With Markers of Acute Infectious Disease Among 9- to 59-Month-Old Children in the Democratic Republic of the Congo.
    Ashbaugh HR; Cherry JD; Hoff NA; Doshi RH; Alfonso VH; Gadoth A; Mukadi P; Higgins SG; Budd R; Randall C; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Gerber SK; Rimoin AW
    J Pediatric Infect Dis Soc; 2019 Dec; 8(6):531-538. PubMed ID: 30346573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of immunization on measles incidence in the Democratic Republic of Congo: Results from a model of surveillance data.
    Doshi RH; Shidi C; Mulumba A; Eckhoff P; Nguyen C; Hoff NA; Gerber S; Okitolonda E; Ilunga BK; Rimoin AW
    Vaccine; 2015 Nov; 33(48):6786-92. PubMed ID: 26476363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antecedent causes of a measles resurgence in the Democratic Republic of the Congo.
    Scobie HM; Ilunga BK; Mulumba A; Shidi C; Coulibaly T; Obama R; Tamfum JJ; Simbu EP; Smit SB; Masresha B; Perry RT; Alleman MM; Kretsinger K; Goodson J
    Pan Afr Med J; 2015; 21():30. PubMed ID: 26401224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal age for vaccination against measles in the State of São Paulo, Brazil, taking into account the mother's serostatus.
    Zanetta RA; Amaku M; Azevedo RS; Zanetta DM; Burattini MN; Massad E
    Vaccine; 2001 Oct; 20(1-2):226-34. PubMed ID: 11567768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of Mumps Infection Among Children in the Democratic Republic of Congo.
    Doshi RH; Alfonso VH; Hoff NA; Mukadi P; Gerber S; Bwaka A; Higgins SG; Mwamba GN; Okitolonda E; Muyembe JJ; Rimoin AW
    Pediatr Infect Dis J; 2017 May; 36(5):462-466. PubMed ID: 28002360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
    Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW
    Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles vaccination coverage estimates from surveys, clinic records, and immune markers in oral fluid and blood: a population-based cross-sectional study.
    Hayford KT; Shomik MS; Al-Emran HM; Moss WJ; Bishai D; Levine OS
    BMC Public Health; 2013 Dec; 13():1211. PubMed ID: 24359402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of human immunodeficiency virus-1 infection and stunting on measles immunoglobulin-G levels in children vaccinated against measles in Uganda.
    Waibale P; Bowlin SJ; Mortimer EA; Whalen C
    Int J Epidemiol; 1999 Apr; 28(2):341-6. PubMed ID: 10342701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a rapid digital microfluidics-powered immunoassay for assessing measles and rubella infection and immunity in outbreak settings in the Democratic Republic of the Congo.
    Knipes AK; Summers A; Sklavounos AA; Lamanna J; de Campos RPS; Narahari T; Dixon C; Fobel R; Ndjakani YD; Lubula L; Magazani A; Muyembe JJ; Lay Y; Pukuta E; Waku-Kouomou D; Hao L; Kayembe JK; Fobel C; Dahmer J; Lee A; Ho M; Valenzuela JGC; Rackus DG; Shih R; Seale B; Chang A; Paluku G; Rota PA; Wheeler AR; Scobie HM
    PLoS One; 2022; 17(12):e0278749. PubMed ID: 36542608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles control in Kinshasa, Zaire improved with high coverage and use of medium titre Edmonston Zagreb vaccine at age 6 months.
    Cutts FT; Othepa O; Vernon AA; Nyandu B; Markowitz LE; Deforest A; Wilkins K; Okwo B
    Int J Epidemiol; 1994 Jun; 23(3):624-31. PubMed ID: 7960392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of measles and natural rubella antibodies among children in Bangui, Central African Republic.
    Manirakiza A; Kipela JM; Sosler S; Daba RM; Gouandjika-Vasilache I
    BMC Public Health; 2011 May; 11():327. PubMed ID: 21586151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Estimates of Crude and Effective Coverage of Measles Immunization in Low-Resource Settings: Findings from Salud Mesoamérica 2015.
    Colson KE; Zúñiga-Brenes P; Ríos-Zertuche D; Conde-Glez CJ; Gagnier MC; Palmisano E; Ranganathan D; Usmanova G; Salvatierra B; Nazar A; Tristao I; Sanchez Monin E; Anderson BW; Haakenstad A; Murphy T; Lim S; Hernandez B; Lozano R; Iriarte E; Mokdad AH
    PLoS One; 2015; 10(7):e0130697. PubMed ID: 26136239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.